^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CART-TM4SF1

    i
    Other names: CART-TM4SF1, TM4SF1-positive chimeric antigen receptor T-cell therapy
    Associations
    News
    Trials
    Company:
    Shanghai Ultra-T Immune Therap
    Drug class:
    TM4SF1-targeted CAR-T immunotherapy
    Associations
    News
    Trials